Mark Puder

Mark Puder, MD, PhD

Associate in Surgery

Professor of Surgery, Harvard Medical School

  • Contact: 617-355-1838

  • Fax: 617-730-0477

Medical Services

Specialties

  • General Surgery
  • Thoracic Surgery
  • Neonatal Surgery
  • Hepatobiliary Surgery
  • Circumcision
  • Undescended Testicles

Departments

  • Surgery

Programs

  • Center for Advanced Intestinal Rehabilitation (CAIR)
  • Surgery Program
To schedule an appointment: Call 617-355-1838 or Request an Appointment

Experience and Education

Education

Graduate School

Harvard University,

Medical School

Vanderbilt University School of Medicine, 1986

Nashville, TN

Internship

New England Deaconess Hospital,

Boston, Ma

Internship

Yale New Haven Hospital,

New Haven, CT

Residency

Beth Isreal Deaconess Hospital,

Boston, Ma

Fellowship

Children's Hospital Boston,

Boston, Ma

Certifications

  • Surgery, Pediatric Surgery

Publications

Publications powered by Harvard Catalyst
  1. Nandivada P, Fell GL, Pan AH, Nose V, Ling PR, Bistrian BR, Puder M. Eucaloric Ketogenic Diet Reduces Hypoglycemia and Inflammation in Mice with Endotoxemia. Lipids. 2016 Jun; 51(6):703-14.
  2. Nandivada P, Fell GL, Gura KM, Puder M. Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children. Am J Clin Nutr. 2016 Feb; 103(2):629S-34S.
  3. Fell GL, Nandivada P, Gura KM, Puder M. Intravenous Lipid Emulsions in Parenteral Nutrition. Adv Nutr. 2015 Sep; 6(5):600-10.
  4. Kalish BT, Fell GL, Nandivada P, Puder M. Clinically Relevant Mechanisms of Lipid Synthesis, Transport, and Storage. JPEN J Parenter Enteral Nutr. 2015 Sep; 39(1 Suppl):8S-17S.
  5. Kalish BT, Matte A, Andolfo I, Iolascon A, Weinberg O, Ghigo A, Cimino J, Siciliano A, Hirsch E, Federti E, Puder M, Brugnara C, De Franceschi L. Dietary ?-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease. Haematologica. 2015 Jul; 100(7):870-80.
  6. Chang MI, Carlson SJ, Nandivada P, O'Loughlin AA, Potemkin AK, Cowan E, Mitchell PD, Gura KM, Puder M. Challenging the 48-Hour Rule-Out for Central Line-Associated Bloodstream Infections in the Pediatric Intestinal Failure Population: A Retrospective Pilot Study. JPEN J Parenter Enteral Nutr. 2016 May; 40(4):567-73.
  7. Nandivada P, Chang MI, Potemkin AK, Carlson SJ, Cowan E, O'loughlin AA, Mitchell PD, Gura KM, Puder M. The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy. Ann Surg. 2015 Jan; 261(1):172-9.
  8. Carlson SJ, Nandivada P, Chang MI, Mitchell PD, O'Loughlin A, Cowan E, Gura KM, Nose V, Bistrian BR, Puder M. The addition of medium-chain triglycerides to a purified fish oil-based diet alters inflammatory profiles in mice. Metabolism. 2015 Feb; 64(2):274-82.
  9. Nandivada P, Potemkin AK, Carlson SJ, Chang MI, Cowan E, O'Loughlin AA, Gura KM, Puder M. Elevated Alkaline Phosphatase in Infants With Parenteral Nutrition-Associated Liver Disease Reflects Bone Rather Than Liver Disease. JPEN J Parenter Enteral Nutr. 2015 Nov; 39(8):973-6.
  10. Fallon EM, Mitchell PD, Nehra D, Potemkin AK, O'Loughlin AA, Gura KM, Puder M. Neonates with short bowel syndrome: an optimistic future for parenteral nutrition independence. JAMA Surg. 2014 Jul; 149(7):663-70.
  11. Show all
  12. Fallon EM, Nazarian A, Nehra D, Pan AH, O'Loughlin AA, Nose V, Puder M. The effect of docosahexaenoic acid on bone microstructure in young mice and bone fracture in neonates. J Surg Res. 2014 Sep; 191(1):148-55.
  13. Nehra D, Pan AH, Le HD, Fallon EM, Carlson SJ, Kalish BT, Puder M. Docosahexaenoic acid, G protein-coupled receptors, and melanoma: is G protein-coupled receptor 40 a potential therapeutic target? J Surg Res. 2014 May 15; 188(2):451-8.
  14. Nandivada P, Carlson SJ, Chang MI, Cowan E, Gura KM, Puder M. Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions. Adv Nutr. 2013 Nov; 4(6):711-7.
  15. Carlson SJ, Chang MI, Nandivada P, Cowan E, Puder M. Neonatal intestinal physiology and failure. Semin Pediatr Surg. 2013 Nov; 22(4):190-4.
  16. Fallon EM, Nehra D, Carlson SJ, Brown DW, Nedder AP, Rueda BR, Puder M. Evaluation of anastomotic strength and drug safety after short-term sunitinib administration in rabbits. J Surg Res. 2014 Mar; 187(1):101-6.
  17. Kalish BT, Le HD, Fitzgerald JM, Wang S, Seamon K, Gura KM, Gronert K, Puder M. Intravenous fish oil lipid emulsion promotes a shift toward anti-inflammatory proresolving lipid mediators. Am J Physiol Gastrointest Liver Physiol. 2013 Dec; 305(11):G818-28.
  18. Nandivada P, Carlson SJ, Cowan E, Chang MI, Gura KM, Puder M. Role of parenteral lipid emulsions in the preterm infant. Early Hum Dev. 2013 Oct; 89 Suppl 2:S45-9.
  19. Glotzbecker MP, Gold M, Puder M, Hresko MT. Scoliosis after chest wall resection. J Child Orthop. 2013 Oct; 7(4):301-7.
  20. Panigrahy D, Kalish BT, Huang S, Bielenberg DR, Le HD, Yang J, Edin ML, Lee CR, Benny O, Mudge DK, Butterfield CE, Mammoto A, Mammoto T, Inceoglu B, Jenkins RL, Simpson MA, Akino T, Lih FB, Tomer KB, Ingber DE, Hammock BD, Falck JR, Manthati VL, Kaipainen A, D'Amore PA, Puder M, Zeldin DC, Kieran MW. Epoxyeicosanoids promote organ and tissue regeneration. Proc Natl Acad Sci U S A. 2013 Aug 13; 110(33):13528-33.
  21. Nehra D, Fallon EM, Potemkin AK, Voss SD, Mitchell PD, Valim C, Belfort MB, Bellinger DC, Duggan C, Gura KM, Puder M. A comparison of 2 intravenous lipid emulsions: interim analysis of a randomized controlled trial. JPEN J Parenter Enteral Nutr. 2014 Aug; 38(6):693-701.
  22. Kalish BT, Kieran MW, Puder M, Panigrahy D. The growing role of eicosanoids in tissue regeneration, repair, and wound healing. Prostaglandins Other Lipid Mediat. 2013 Jul-Aug; 104-105:130-8.
  23. Nehra D, Carlson SJ, Fallon EM, Kalish B, Potemkin AK, Gura KM, Simpser E, Compher C, Puder M. A.S.P.E.N. clinical guidelines: nutrition support of neonatal patients at risk for metabolic bone disease. JPEN J Parenter Enteral Nutr. 2013 Sep; 37(5):570-98.
  24. Nandivada P, Cowan E, Carlson SJ, Chang M, Gura KM, Puder M. Mechanisms for the effects of fish oil lipid emulsions in the management of parenteral nutrition-associated liver disease. Prostaglandins Leukot Essent Fatty Acids. 2013 Sep; 89(4):153-8.
  25. Kalish BT, Le HD, Gura KM, Bistrian BR, Puder M. A metabolomic analysis of two intravenous lipid emulsions in a murine model. PLoS One. 2013; 8(4):e59653.
  26. Cowan E, Nandivada P, Puder M. Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated liver disease. Curr Opin Pediatr. 2013 Apr; 25(2):193-200.
  27. Chang MI, Puder M, Gura KM. The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD). Nutrients. 2012 Dec; 4(12):1828-50.
  28. Carlson SJ, Fallon EM, Kalish BT, Gura KM, Puder M. The role of the ?-3 fatty acid DHA in the human life cycle. JPEN J Parenter Enteral Nutr. 2013 Jan; 37(1):15-22.
  29. Fallon EM, Nehra D, Potemkin AK, Gura KM, Simpser E, Puder M, Compher C. Response to Meyer and Gortner. JPEN J Parenter Enteral Nutr. 2013 Jan; 37(1):13-4.
  30. Le HD, Fallon EM, Kalish BT, de Meijer VE, Meisel JA, Gura KM, Nose V, Pan AH, Bistrian BR, Puder M. The effect of varying ratios of docosahexaenoic acid and arachidonic acid in the prevention and reversal of biochemical essential fatty acid deficiency in a murine model. Metabolism. 2013 Apr; 62(4):499-508.
  31. Nehra D, Le HD, Fallon EM, Carlson SJ, Woods D, White YA, Pan AH, Guo L, Rodig SJ, Tilly JL, Rueda BR, Puder M. Prolonging the female reproductive lifespan and improving egg quality with dietary omega-3 fatty acids. Aging Cell. 2012 Dec; 11(6):1046-54.
  32. Fallon EM, Nehra D, Potemkin AK, Gura KM, Simpser E, Puder M, Compher C. Response to the letter to the editor regarding Nutrition support of neonatal patients at risk for necrotizing enterocolitis. JPEN J Parenter Enteral Nutr. 2013 Jan; 37(1):12.
  33. Fallon EM, Mitchell PD, Potemkin AK, Nehra D, Arsenault DA, Robinson EM, Zurakowski D, Brenn M, Meisel JA, Puder M. Cholestasis and growth in neonates with gastroschisis. J Pediatr Surg. 2012 Aug; 47(8):1529-36.
  34. Fallon EM, Nehra D, Carlson SJ, Potemkin AK, Mitchell PD, Nedder AP, Rueda BR, Puder M. Sunitinib reduces recurrent pelvic adhesions in a rabbit model. J Surg Res. 2012 Dec; 178(2):860-5.
  35. Nehra D, Fallon EM, Carlson SJ, Potemkin AK, Hevelone ND, Mitchell PD, Gura KM, Puder M. Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates. JPEN J Parenter Enteral Nutr. 2013 Jul; 37(4):498-505.
  36. Arsenault D, Brenn M, Gura KM, Compher C, Simpser E, Puder M. Hyperglycemia in the newborn--correctly reported. JPEN J Parenter Enteral Nutr. 2012 Jul; 36(4):379.
  37. Fallon EM, Nehra D, Potemkin AK, Gura KM, Simpser E, Compher C, Puder M. A.S.P.E.N. clinical guidelines: nutrition support of neonatal patients at risk for necrotizing enterocolitis. JPEN J Parenter Enteral Nutr. 2012 Sep; 36(5):506-23.
  38. de Meijer VE, Kalish BT, Meisel JA, Le HD, Puder M. Dietary fish oil aggravates paracetamol-induced liver injury in mice. JPEN J Parenter Enteral Nutr. 2013 Mar; 37(2):268-73.
  39. Fallon EM, Nehra D, Le HD, Nedder AP, Guo L, Mitchell PD, Rueda BR, Puder M. Effect of sunitinib on functional reproductive outcome in a rabbit model. Fertil Steril. 2012 Aug; 98(2):496-502.
  40. Kalish BT, Fallon EM, Puder M. A tutorial on fatty acid biology. JPEN J Parenter Enteral Nutr. 2012 Jul; 36(4):380-8.
  41. Ling PR, Puder M, Bistrian BR. Purified fish oil eliminating linoleic and alpha linolenic acid meets essential fatty acid requirements in rats. Metabolism. 2012 Oct; 61(10):1443-51.
  42. de Meijer VE, Sverdlov DY, Le HD, Popov Y, Puder M. Tissue-specific differences in inflammatory infiltrate and matrix metalloproteinase expression in adipose tissue and liver of mice with diet-induced obesity. Hepatol Res. 2012 Jun; 42(6):601-10.
  43. Barnés CM, Prox D, Christison-Lagay EA, Le HD, Short S, Cassiola F, Panigrahy D, Chaponis D, Butterfield C, Nehra D, Fallon EM, Kieran M, Folkman J, Puder M. Inhibition of neuroblastoma cell proliferation with omega-3 fatty acids and treatment of a murine model of human neuroblastoma using a diet enriched with omega-3 fatty acids in combination with sunitinib. Pediatr Res. 2012 Feb; 71(2):168-78.
  44. Arsenault D, Brenn M, Kim S, Gura K, Compher C, Simpser E, Puder M. A.S.P.E.N. Clinical Guidelines: hyperglycemia and hypoglycemia in the neonate receiving parenteral nutrition. JPEN J Parenter Enteral Nutr. 2012 Jan; 36(1):81-95.
  45. Fuchs J, Fallon EM, Gura KM, Puder M. Use of an omega-3 fatty acid-based emulsion in the treatment of parenteral nutrition-induced cholestasis in patients with microvillous inclusion disease. J Pediatr Surg. 2011 Dec; 46(12):2376-82.
  46. Le HD, Meisel JA, de Meijer VE, Fallon EM, Gura KM, Nose V, Bistrian BR, Puder M. Docosahexaenoic acid and arachidonic acid prevent essential fatty acid deficiency and hepatic steatosis. JPEN J Parenter Enteral Nutr. 2012 Jul; 36(4):431-41.
  47. de Meijer VE, Le HD, Meisel JA, Sharma AK, Popov Y, Puder M. Tumor necrosis factor a-converting enzyme inhibition reverses hepatic steatosis and improves insulin sensitivity markers and surgical outcome in mice. PLoS One. 2011; 6(9):e25587.
  48. Ling PR, Malkan A, Le HD, Puder M, Bistrian BR. Arachidonic acid and docosahexaenoic acid supplemented to an essential fatty acid-deficient diet alters the response to endotoxin in rats. Metabolism. 2012 Mar; 61(3):395-406.
  49. Le HD, de Meijer VE, Robinson EM, Zurakowski D, Potemkin AK, Arsenault DA, Fallon EM, Malkan A, Bistrian BR, Gura KM, Puder M. Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children. Am J Clin Nutr. 2011 Sep; 94(3):749-58.
  50. Lei NY, Ma G, Zupekan T, Stark R, Puder M, Dunn JC. Controlled release of vascular endothelial growth factor enhances intestinal adaptation in rats with extensive small intestinal resection. Surgery. 2011 Aug; 150(2):186-90.
  51. Meisel JA, Fallon EM, Le HD, Nehra D, de Meijer VE, Rodig SJ, Puder M. Sunitinib inhibits postoperative adhesions in a rabbit model. Surgery. 2011 Jul; 150(1):32-8.
  52. Nehra D, Fallon EM, Puder M. The prevention and treatment of intestinal failure-associated liver disease in neonates and children. Surg Clin North Am. 2011 Jun; 91(3):543-63.
  53. Meisel JA, Le HD, de Meijer VE, Nose V, Gura KM, Mulkern RV, Akhavan Sharif MR, Puder M. Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model. J Pediatr Surg. 2011 Apr; 46(4):666-73.
  54. Arsenault DA, Potemkin AK, Robinson EM, Fallon EM, Ozonoff A, de Meijer VE, Puder M. Surgical intervention in the setting of parenteral nutrition-associated cholestasis may exacerbate liver injury. J Pediatr Surg. 2011 Jan; 46(1):122-7.
  55. de Meijer VE, Kalish BT, Puder M, Ijzermans JN. Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg. 2010 Sep; 97(9):1331-9.
  56. Le HD, de Meijer VE, Zurakowski D, Meisel JA, Gura KM, Puder M. Parenteral fish oil as monotherapy improves lipid profiles in children with parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr. 2010 Sep-Oct; 34(5):477-84.
  57. Ling PR, De Leon CE, Le H, Puder M, Bistrian BR. Early development of essential fatty acid deficiency in rats: fat-free vs. hydrogenated coconut oil diet. Prostaglandins Leukot Essent Fatty Acids. 2010 Oct-Dec; 83(4-6):229-37.
  58. Gura KM, Puder M. Rapid infusion of fish oil-based emulsion in infants does not appear to be associated with fat overload syndrome. Nutr Clin Pract. 2010 Aug; 25(4):399-402.
  59. Le HD, Gura KM, Arsenault DA, Fallon EM, Potemkin AK, Puder M. Assessing portal fibrosis in parenteral nutrition-dependent patients treated with omega-3 fatty acid lipid emulsion. J Pediatr. 2010 Sep; 157(3):517; author reply 518.
  60. de Meijer VE, Sverdlov DY, Popov Y, Le HD, Meisel JA, Nosé V, Schuppan D, Puder M. Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice. PLoS One. 2010; 5(6):e11256.
  61. de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease. Arch Surg. 2010 Jun; 145(6):547-51.
  62. Fallon EM, Le HD, Puder M. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil. Curr Opin Organ Transplant. 2010 Jun; 15(3):334-40.
  63. de Meijer VE, Le HD, Meisel JA, Puder M. Repetitive orogastric gavage affects the phenotype of diet-induced obese mice. Physiol Behav. 2010 Jun 16; 100(4):387-93.
  64. Novak KB, Le HD, Christison-Lagay ER, Nose V, Doiron RJ, Moses MA, Puder M. Effects of metalloproteinase inhibition in a murine model of renal ischemia-reperfusion injury. Pediatr Res. 2010 Mar; 67(3):257-62.
  65. Le HD, Fallon EM, de Meijer VE, Malkan AD, Puder M, Gura KM. Innovative parenteral and enteral nutrition therapy for intestinal failure. Semin Pediatr Surg. 2010 Feb; 19(1):27-34.
  66. de Meijer VE, Le HD, Meisel JA, Gura KM, Puder M. Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J Pediatr Gastroenterol Nutr. 2010 Feb; 50(2):212-8.
  67. Ling PR, Andersson C, Strijbosch R, Lee S, Silvestri A, Gura KM, Puder M, Bistrian BR. Effects of glucose or fat calories in total parenteral nutrition on fat metabolism and systemic inflammation in rats. Metabolism. 2011 Feb; 60(2):195-205.
  68. de Meijer VE, Le HD, Meisel JA, Akhavan Sharif MR, Pan A, Nosé V, Puder M. Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model. Metabolism. 2010 Aug; 59(8):1092-105.
  69. de Meijer VE, Gura KM, Puder M. Parenteral nutrition in the critically ill patient. N Engl J Med. 2010 Jan 7; 362(1):81-2; author reply 83-4.
  70. Lee SI, Valim C, Johnston P, Le HD, Meisel J, Arsenault DA, Gura KM, Puder M. Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease. Pediatr Res. 2009 Dec; 66(6):698-703.
  71. Puder M, Valim C, Meisel JA, Le HD, de Meijer VE, Robinson EM, Zhou J, Duggan C, Gura KM. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg. 2009 Sep; 250(3):395-402.
  72. de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr. 2009 Sep-Oct; 33(5):541-7.
  73. Le HD, Meisel JA, de Meijer VE, Gura KM, Puder M. The essentiality of arachidonic acid and docosahexaenoic acid. Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep; 81(2-3):165-70.
  74. Puder M. Infant parenteral nutrition-associated cholestasis: a severe iatrogenic disease. JPEN J Parenter Enteral Nutr. 2010 Jan-Feb; 34(1):94-5.
  75. Goessling W, North TE, Loewer S, Lord AM, Lee S, Stoick-Cooper CL, Weidinger G, Puder M, Daley GQ, Moon RT, Zon LI. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell. 2009 Mar 20; 136(6):1136-47.
  76. Lee S, Kim S, Le HD, Meisel J, Strijbosch RA, Nose V, Puder M. Reduction of hepatocellular injury after common bile duct ligation using omega-3 fatty acids. J Pediatr Surg. 2008 Nov; 43(11):2010-5.
  77. de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M. Parenteral fish oil as monotherapy for patients with parenteral nutrition-associated liver disease. Pediatr Surg Int. 2009 Jan; 25(1):123-4.
  78. Kim S, Lee S, Arsenault DA, Strijbosch RA, Shamberger RC, Puder M. Pediatric rib lesions: a 13-year experience. J Pediatr Surg. 2008 Oct; 43(10):1781-5.
  79. Blackman SC, Evenson AR, Voss SD, Barnewolt CE, Puder M. Prenatal diagnosis and subsequent treatment of an intermediate-risk paraspinal neuroblastoma: case report and review of the literature. Fetal Diagn Ther. 2008; 24(2):119-25.
  80. Henkes LE, Sullivan BT, Lynch MP, Kolesnick R, Arsenault D, Puder M, Davis JS, Rueda BR. Acid sphingomyelinase involvement in tumor necrosis factor alpha-regulated vascular and steroid disruption during luteolysis in vivo. Proc Natl Acad Sci U S A. 2008 Jun 3; 105(22):7670-5.
  81. Goessling W, North TE, Lord AM, Ceol C, Lee S, Weidinger G, Bourque C, Strijbosch R, Haramis AP, Puder M, Clevers H, Moon RT, Zon LI. APC mutant zebrafish uncover a changing temporal requirement for wnt signaling in liver development. Dev Biol. 2008 Aug 1; 320(1):161-74.
  82. Strijbosch RA, Lee S, Arsenault DA, Andersson C, Gura KM, Bistrian BR, Puder M. Fish oil prevents essential fatty acid deficiency and enhances growth: clinical and biochemical implications. Metabolism. 2008 May; 57(5):698-707.
  83. Page MP, Ricca RL, Resnick AS, Puder M, Fishman SJ. Newborn and toddler intestinal obstruction owing to congenital mesenteric defects. J Pediatr Surg. 2008 Apr; 43(4):755-8.
  84. Gura KM, Lee S, Valim C, Zhou J, Kim S, Modi BP, Arsenault DA, Strijbosch RA, Lopes S, Duggan C, Puder M. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics. 2008 Mar; 121(3):e678-86.
  85. Lee S, Gura KM, Puder M. Re: Influence of different intravenous lipid emulsions on hepatobiliary dysfunction in a rabbit model. J Pediatr Gastroenterol Nutr. 2008 Feb; 46(2):224-5; author reply 225.
  86. Alwayn IP, Verbesey JE, Kim S, Roy R, Arsenault DA, Greene AK, Novak K, Laforme A, Lee S, Moses MA, Puder M. A critical role for matrix metalloproteinases in liver regeneration. J Surg Res. 2008 Apr; 145(2):192-8.
  87. Gura K, Strijbosch R, Arnold S, McPherson C, Puder M. The role of an intravenous fat emulsion composed of fish oil in a parenteral nutrition-dependent patient with hypertriglyceridemia. Nutr Clin Pract. 2007 Dec; 22(6):664-72.
  88. Kim S, Lee S, Greene AK, Arsenault DA, Le H, Meisel J, Novak K, Flynn E, Heymach JV, Puder M. Inhibition of intra-abdominal adhesion formation with the angiogenesis inhibitor sunitinib. J Surg Res. 2008 Sep; 149(1):115-9.
  89. Styer AK, Sullivan BT, Puder M, Arsenault D, Petrozza JC, Serikawa T, Chang S, Hasan T, Gonzalez RR, Rueda BR. Ablation of leptin signaling disrupts the establishment, development, and maintenance of endometriosis-like lesions in a murine model. Endocrinology. 2008 Feb; 149(2):506-14.
  90. Beaudry P, Hida Y, Udagawa T, Alwayn IP, Greene AK, Arsenault D, Folkman J, Heymach JV, Ryeom S, Puder M. Endothelial progenitor cells contribute to accelerated liver regeneration. J Pediatr Surg. 2007 Jul; 42(7):1190-8.
  91. Lee S, Gura KM, Puder M. Omega-3 fatty acids and liver disease. Hepatology. 2007 Apr; 45(4):841-5.
  92. Sakurai MK, Lee S, Arsenault DA, Nose V, Wilson JM, Heymach JV, Puder M. Vascular endothelial growth factor accelerates compensatory lung growth after unilateral pneumonectomy. Am J Physiol Lung Cell Mol Physiol. 2007 Mar; 292(3):L742-7.
  93. Kim S, Linden B, Cendron M, Puder M. Pediatric anorectal impalement with bladder rupture: case report and review of the literature. J Pediatr Surg. 2006 Sep; 41(9):E1-3.
  94. Lee S, Gura KM, Kim S, Arsenault DA, Bistrian BR, Puder M. Current clinical applications of omega-6 and omega-3 fatty acids. Nutr Clin Pract. 2006 Aug; 21(4):323-41.
  95. Alwayn IP, Andersson C, Lee S, Arsenault DA, Bistrian BR, Gura KM, Nose V, Zauscher B, Moses M, Puder M. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model. Am J Physiol Gastrointest Liver Physiol. 2006 Dec; 291(6):G1011-9.
  96. Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR, Puder M. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics. 2006 Jul; 118(1):e197-201.
  97. Gura KM, Puder M. Recent developments in aluminium contamination of products used in parenteral nutrition. Curr Opin Clin Nutr Metab Care. 2006 May; 9(3):239-46.
  98. Greene AK, Puder M, Roy R, Arsenault D, Kwei S, Moses MA, Orgill DP. Microdeformational wound therapy: effects on angiogenesis and matrix metalloproteinases in chronic wounds of 3 debilitated patients. Ann Plast Surg. 2006 Apr; 56(4):418-22.
  99. Kim S, Gura KM, Puder M. Acute necrotizing cholecystitis: a rare complication of ceftriaxone-associated pseudolithiasis. Pediatr Surg Int. 2006 Jun; 22(6):562-4.
  100. Greene AK, Zurakowski D, Puder M, Thompson K. Determining the need for simulated training of invasive procedures. Adv Health Sci Educ Theory Pract. 2006 Feb; 11(1):41-9.
  101. Udagawa T, Puder M, Wood M, Schaefer BC, D'Amato RJ. Analysis of tumor-associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow-derived host cells. FASEB J. 2006 Jan; 20(1):95-102.
  102. Gura K, Lee S, Puder M. . Tools for living better on home IV & tube feedings: HPN-Associated Liver Disease in Infants. 2006.
  103. Arsenault D and Puder M. Metabolic bone disease. American Society for Parenteral and Enteral Nutrition Clinical Guidelines. 2006.
  104. Kim S and Puder M. Hyper and hypoglycemia of the neonate. American Society for Parenteral and Enteral Nutrition Clinical Guidelines. 2006.
  105. Lee S and Puder M. Necrotizing enterocolitis. American Society for Parenteral and Enteral Nutrition Clinical Guidelines. 2006.
  106. Use of Omega 3 Fatty Acids to Improve Liver Transplant Survival. 2006.
  107. Lee S and Puder M. Hepatobiliary. American Society for Parenteral and Enteral Nutrition Clinical Guidelines. 2006.
  108. Hands-Free Medical Device Management Waste Disposal System (Operating Room Table Sharps Container). 2006.
  109. Beaudry P, Hida Y, Ryeom S, Udagawa T, Norden-Zfoni A, Alwayn IP, Arsenault D, Greene AK, Molofsky D, Prox D, Folkman J, John V. Heymach JV, Puder M. . Distinct populations of circulating endothelial cells regulate liver regeneration and are an index of endothelial damage. J Pediatr Surg. 2006.
  110. Strijbosch R and Puder M. Hypertriglyceridemia. American Society for Parenteral and Enteral Nutrition Clinical Guidelines. 2006.
  111. Gura KM, Parsons SK, Bechard LJ, Henderson T, Dorsey M, Phipatanakul W, Duggan C, Puder M, Lenders C. Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr. 2005 Oct; 24(5):839-47.
  112. Javid PJ, Greene AK, Garza J, Gura K, Alwayn IP, Voss S, Nose V, Satchi-Fainaro R, Zausche B, Mulkern RV, Jaksic T, Bistrian B, Folkman J, Puder M. The route of lipid administration affects parenteral nutrition-induced hepatic steatosis in a mouse model. J Pediatr Surg. 2005 Sep; 40(9):1446-53.
  113. Gura KM, Puder M. Safety of an Intravenous Fish Oil Fat Emulsion When Used as Monotherapy in Infants Receiving Parenteral Nutrition: Preliminary Findings. European Society for Clinical Nutrition and Metabolism (ESPEN), 27th Congress of ESPEN, Brussels, Belgium. 2005.
  114. Sakurai MK, Greene AK, Wilson J, Fauza D, Puder M. Pneumonectomy in the mouse: technique and perioperative management. J Invest Surg. 2005 Jul-Aug; 18(4):201-5.
  115. Greene AK, Alwayn IP, Nose V, Flynn E, Sampson D, Zurakowski D, Folkman J, Puder M. Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib. Ann Surg. 2005 Jul; 242(1):140-6.
  116. Rothstein DH, Voss SD, Isakoff M, Puder M. Thymoma in a child: case report and review of the literature. Pediatr Surg Int. 2005 Jul; 21(7):548-51.
  117. Patient-Friendly Stethoscope . 2005.
  118. Alwayn IP, Andersson C, Zauscher B, Gura K, Nosé V, Puder M. Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor. Transplantation. 2005 Mar 15; 79(5):606-8.
  119. Satchi-Fainaro R, Mamluk R, Wang L, Short SM, Nagy JA, Feng D, Dvorak AM, Dvorak HF, Puder M, Mukhopadhyay D, Folkman J. Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell. 2005 Mar; 7(3):251-61.
  120. Alwayn IP, Gura K, Nosé V, Zausche B, Javid P, Garza J, Verbesey J, Voss S, Ollero M, Andersson C, Bistrian B, Folkman J, Puder M. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res. 2005 Mar; 57(3):445-52.
  121. Jedele K, Morash D, Kasser J, Puder M, Marchaand K, Kimonis V, Levine D. Anal malformations in a two-generation family with split feet and TP63 mutation. 2005.
  122. Treatment and Prevention of Fatty Liver Disease Associated with Total Parenteral Nutrition (TPN). 2004.
  123. Greene AK, Puder M, Roy R, Kilroy S, Louis G, Folkman J, Moses MA. Urinary matrix metalloproteinases and their endogenous inhibitors predict hepatic regeneration after murine partial hepatectomy. Transplantation. 2004 Oct 27; 78(8):1139-44.
  124. Method of Treating Fatty Liver Disease (MMPs). 2004.
  125. Alwayn IP, Javid PJ, Gura KM, Nosé V, Ollero M, Puder M. Do polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREPB-1 suppression or by correcting essential fatty acid deficiency. Hepatology. 2004 Apr; 39(4):1176-7; author reply 1177-8.
  126. Prevention of Surgical Adhesions via VEGF Receptor 2. 2004.
  127. Satchi-Fainaro R, Puder M, Davies JW, Tran HT, Sampson DA, Greene AK, Corfas G, Folkman J. Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nat Med. 2004 Mar; 10(3):255-61.
  128. Prevention of Surgical Adhesions Using Selective COX-2 Inhibitors. 2004.
  129. Greene AK, Wiener S, Puder M, Yoshida A, Shi B, Perez-Atayde AR, Efstathiou JA, Holmgren L, Adamis AP, Rupnick M, Folkman J, O'Reilly MS. Endothelial-directed hepatic regeneration after partial hepatectomy. Ann Surg. 2003 Apr; 237(4):530-5.
  130. Greene AK, Puder M. Partial hepatectomy in the mouse: technique and perioperative management. J Invest Surg. 2003 Mar-Apr; 16(2):99-102.
  131. McAlmon K, Puder M. GI bleeding. Hansen A, Puder M, editors. Manual of Neonatal Surgical Intensive Care. 2003.
  132. Bousvaros A, Puder M. Gastrostomy tubes. Hansen A, Puder M, editors. Manual of Neonatal Surgical Intensive Care. 2003.
  133. Greene A, Hanson A, Puder M. Vascular access. Hansen A, Puder M. editors. Manual of Neonatal Surgical Intensive Care. 2003.
  134. Puder M. General surgical considerations. Hansen A, Puder M, editors. Manual of Neonatal Surgical Intensive Care. 2003.
  135. Pursley D, Puder M. Bowel obstruction. Hansen A, Puder M, editors. Manual of Neonatal Surgical Intensive Care. 2003.
  136. Greene A, Puder M. Chylothorax. Hansen A, Puder M, editors, Manual of Neonatal Surgical Intensive Care. 2003.
  137. Greene A, Puder M. Inguinal Hernia. Hansen A, Puder M, editors. Manual of Neonatal Surgical Intensive Care. 2003.
  138. Hansen A, Puder M. editors. Manual of Neonatal Surgical Intensive Care. 2003.
  139. Quigley S, Hansen A, Puder M. Stoma management. Hansen A, Puder M, editors. Manual of Neonatal Surgical Intensive Care. 2003.
  140. Puder M, Greene A, Mooney D. Hepatic exstrophy complicating Poland's anomaly. J Pediatr Surg. 2002 Aug; 37(8):1203-4.
  141. Greene AK, Puder M. A resident's guide to personal finance. Curr Surg. 2002 Jul-Aug; 59(4):423-5.
  142. Veil JA, Puder MG, Littleton DJ, Johnson N. A holistic look at minimizing adverse environmental impact under Section 316(b) of the Clean Water Act. ScientificWorldJournal. 2002 Apr 18; 2 Suppl 1:41-57.
  143. Fishman SJ, Puder M, Geva T, Jenkins K, Ziegler MM, Shamberger RC. Cardiac relocation and chest wall reconstruction after separation of thoracopagus conjoined twins with a single heart. J Pediatr Surg. 2002 Mar; 37(3):515-7.
  144. Greene AK, Puder M. A resident's guide to personal finance. Curr Surg. 2002.
  145. Puder, M. Intracellular binding of leukotriene C4 and glutathione conjugates [dissertation]. 1998.
  146. Puder M, Soberman RJ. Glutathione conjugates recognize the Rossmann fold of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem. 1997 Apr 18; 272(16):10936-40.
  147. Kim J, Puder M, Soberman RJ. Joining of DNA fragments by repeated cycles of denaturation, annealing and extension. Biotechniques. 1996 Jun; 20(6):954-5.
  148. Puder M, Soberman RJ. Arachidonic acid-derived mediators of inflammation. Tilney NC, Strom TB, et al, editors. Transplantation Biology: Cellular and Molecular Aspects. 1996.
  149. Barnard GF, Mori M, Staniunas RJ, Begum NA, Bao S, Puder M, Cobb J, Redman KL, Steele GD, Chen LB. Ubiquitin fusion proteins are overexpressed in colon cancer but not in gastric cancer. Biochim Biophys Acta. 1995 Dec 12; 1272(3):147-53.
  150. Barnard GF, Staniunas RJ, Puder M, Steele GD, Chen LB. Human ribosomal protein L37 has motifs predicting serine/threonine phosphorylation and a zinc-finger domain. Biochim Biophys Acta. 1994 Aug 2; 1218(3):425-8.
  151. Barnard GF, Puder M, Begum NA, Chen LB. PCR product sequencing with [alpha-33P] and [alpha-32P]dATP. Biotechniques. 1994 Apr; 16(4):572-3.
  152. Puder M, Barnard GF, Staniunas RJ, Steele GD, Chen LB. Nucleotide and deduced amino acid sequence of human ribosomal protein L18. Biochim Biophys Acta. 1993 Oct 19; 1216(1):134-6.
  153. Barnard GF, Staniunas RJ, Mori M, Puder M, Jessup MJ, Steele GD, Chen LB. Gastric and hepatocellular carcinomas do not overexpress the same ribosomal protein messenger RNAs as colonic carcinoma. Cancer Res. 1993 Sep 1; 53(17):4048-52.
  154. Puder M, Nir I, Siegel RA, Weidenfeld J, Ayalon D. The effect of delta 1tetrahydrocannabinol on luteinizing hormone release in castrated and hypothalamic deafferented male rats. Exp Brain Res. 1985; 59(2):213-6.
  155. Nir I, Puder M. [Analgesic-antipyretic agents: which one?]. Harefuah. 1982 Mar 15; 102(6):258-61.
  156. Puder M, Weidenfeld J, Chowers I, Nir I, Conforti N, Siegel RA. Corticotrophin and corticosterone secretion following delta 1-Tetrahydrocannabinol, in intact and in hypothalamic deafferentated male rats. Exp Brain Res. 1982; 46(1):85-8.
  157. Cordova T, Ayalon D, Lander N, Mechoulam R, Nir I, Puder M, Lindner HR. The ovulation blocking effect of cannabinoids: structure-activity relationships. Psychoneuroendocrinology. 1980 Jan; 5(1):53-62.
  158. Nir I, Hirschmann N, Puder M, Petrank J. Changes in rodent thyroid hormones and cyclic-AMP following treatment with pineal indolic compounds. Arch Int Physiol Biochim. 1978 May; 86(2):353-62.
  159. Ayalon D, Nir I, Cordova T, Bauminger S, Puder M, Naor Z, Kashi R, Zor U, Harell A, Lindner HR. Acute effect of delta1-tetrahydrocannabinol on the hypothalamo-pituitary-ovarian axis in the rat. Neuroendocrinology. 1977; 23(1):31-42.
To schedule an appointment: Call 617-355-1838 or Request an Appointment

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close